Fact CheckerSign in

NCT07317284Completed

Evaluation and Treatment for Diabetic Peripheral Neuropathy

Evaluation of Peripheral Neurological Integrity and Synergistic Treatment of Photobiomodulation and Therapy Ultrasound in Patirnts With Diabetes Mellitus (Type II): Clinical Study

Source: ClinicalTrials.gov · Last updated 13 Jan 2026

Brief summary (registry, in English)

This study aims: * To compare conventional diabetic neuropathy screening techniques with user-friendly technological equipment; * To evaluate the effects of the combined application of laser and therapeutic ultrasound in the treatment of Diabetic Peripheral Neuropathy (DPN) in its early stages, aiming to prevent severe complications, such as the development of diabetic foot. Two groups were formed: Treatment group and placebo group. 24 sessions were performed (twice a week, on alternate days). It is concluded that the combined treatment with laser and therapeutic ultrasound for diabetic peripheral neuropathy promotes a significant reduction in symptoms and improvement in sensitivity in patients with diabetic peripheral neuropathy.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
18 Dec 2025
Start date
10 Jul 2024
Primary completion date
7 Apr 2025
Lead sponsor
University of Sao Paulo
NCT number
NCT07317284

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 10 Jul 2024 to the primary completion date, 7 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Lower limb involvement with metal implants, ankle and foot fractures;
  • Drug use;

Other illness

  • Serious illnesses such as malignant or benign tumors;
  • Hormonal disorders;

Other

  • Diabetic foot;
  • Serious psychological problems;
  • Pacemaker users;
  • Hemodialysis treatment;
  • Physiotherapy treatment for less than six months.

Who the study is looking for

  • Type II diabetes diagnosed between 7 and 15 years old;
  • Age between 45 and 70 years;
  • Sex female and male.

Age in the registry: 45 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Research, Innovation and Development Support Center
Coordinator of this site? Confirm its status
São CarlosBrazilUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.